Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000715812-20-000002
Filing Date
2020-03-12
Accepted
2020-03-12 15:06:47
Documents
43
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 bsyn013120.htm 10-Q 178099
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER bsynx311.htm EX-31.1 10341
3 CERTIFICATION OF CHIEF ACCOUNTING OFFICER bsynx312.htm EX-31.2 9385
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx321.htm EX-32.1 4076
5 bsynx322.htm EX-32 4171
  Complete submission text file 0000715812-20-000002.txt   1230126

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bsyn-20200131.xsd EX-101.SCH 16286
7 XBRL CALCULATION FILE bsyn-20200131_cal.xml EX-101.CAL 37315
8 XBRL DEFINITION FILE bsyn-20200131_def.xml EX-101.DEF 18892
9 XBRL LABEL FILE bsyn-20200131_lab.xml EX-101.LAB 117515
10 XBRL PRESENTATION FILE bsyn-20200131_pre.xml EX-101.PRE 89932
11 XBRL INSTANCE FILE bsyn-20200131.xml EX-101.INS 149366
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-12459 | Film No.: 20708475
SIC: 3829 Measuring & Controlling Devices, NEC